ID S27A3_MOUSE Reviewed; 667 AA. AC O88561; Q6PAU1; Q8BK70; DT 22-NOV-2005, integrated into UniProtKB/Swiss-Prot. DT 22-NOV-2005, sequence version 2. DT 08-NOV-2023, entry version 141. DE RecName: Full=Long-chain fatty acid transport protein 3 {ECO:0000303|PubMed:9671728}; DE Short=FATP-3 {ECO:0000303|PubMed:15469937, ECO:0000303|PubMed:9671728}; DE Short=Fatty acid transport protein 3 {ECO:0000303|PubMed:9671728}; DE AltName: Full=Arachidonate--CoA ligase {ECO:0000303|PubMed:15699031}; DE EC=6.2.1.15 {ECO:0000269|PubMed:15699031}; DE AltName: Full=Long-chain-fatty-acid--CoA ligase; DE EC=6.2.1.3 {ECO:0000269|PubMed:15469937, ECO:0000269|PubMed:15699031}; DE AltName: Full=Solute carrier family 27 member 3 {ECO:0000312|MGI:MGI:1347358}; DE AltName: Full=Very long-chain acyl-CoA synthetase homolog 3 {ECO:0000303|PubMed:15469937}; DE Short=VLCS-3 {ECO:0000303|PubMed:15469937}; DE EC=6.2.1.- {ECO:0000269|PubMed:15469937, ECO:0000269|PubMed:15699031}; GN Name=Slc27a3; Synonyms=Acsvl3, Fatp3; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC STRAIN=C57BL/6J; TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 45-667 (ISOFORM 1). RC STRAIN=C57BL/6J; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 54-667 (ISOFORM 1). RX PubMed=9671728; DOI=10.1073/pnas.95.15.8625; RA Hirsch D., Stahl A., Lodish H.F.; RT "A family of fatty acid transporters conserved from mycobacterium to man."; RL Proc. Natl. Acad. Sci. U.S.A. 95:8625-8629(1998). RN [4] RP FUNCTION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, TISSUE SPECIFICITY, RP AND CATALYTIC ACTIVITY. RX PubMed=15469937; DOI=10.1074/jbc.m410091200; RA Pei Z., Fraisl P., Berger J., Jia Z., Forss-Petter S., Watkins P.A.; RT "Mouse very long-chain acyl-CoA synthetase 3/fatty acid transport protein 3 RT catalyzes fatty acid activation but not fatty acid transport in MA-10 RT cells."; RL J. Biol. Chem. 279:54454-54462(2004). RN [5] RP FUNCTION, CATALYTIC ACTIVITY, AND TRANSPORT ACTIVITY. RX PubMed=15699031; DOI=10.1074/jbc.m409598200; RA DiRusso C.C., Li H., Darwis D., Watkins P.A., Berger J., Black P.N.; RT "Comparative biochemical studies of the murine fatty acid transport RT proteins (FATP) expressed in yeast."; RL J. Biol. Chem. 280:16829-16837(2005). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Lung, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [7] RP TISSUE SPECIFICITY. RX PubMed=23936004; DOI=10.1371/journal.pone.0069392; RA Pei Z., Fraisl P., Shi X., Gabrielson E., Forss-Petter S., Berger J., RA Watkins P.A.; RT "Very long-chain acyl-CoA synthetase 3: overexpression and growth RT dependence in lung cancer."; RL PLoS ONE 8:E69392-E69392(2013). CC -!- FUNCTION: Mainly functions as an acyl-CoA ligase catalyzing the ATP- CC dependent formation of fatty acyl-CoA using LCFA and very-long-chain CC fatty acids (VLCFA) as substrates (PubMed:15469937, PubMed:15699031). CC Can mediate the levels of long-chain fatty acids (LCFA) in the cell by CC facilitating their transport across membranes (PubMed:15699031). CC {ECO:0000269|PubMed:15469937, ECO:0000269|PubMed:15699031}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a fatty acid(in) = a fatty acid(out); Xref=Rhea:RHEA:38879, CC ChEBI:CHEBI:28868; Evidence={ECO:0000269|PubMed:15699031}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a long-chain fatty acid + ATP + CoA = a long-chain fatty acyl- CC CoA + AMP + diphosphate; Xref=Rhea:RHEA:15421, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57560, CC ChEBI:CHEBI:83139, ChEBI:CHEBI:456215; EC=6.2.1.3; CC Evidence={ECO:0000269|PubMed:15699031}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15422; CC Evidence={ECO:0000269|PubMed:15699031}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + ATP + CoA = CC (5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate; CC Xref=Rhea:RHEA:19713, ChEBI:CHEBI:30616, ChEBI:CHEBI:32395, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, CC ChEBI:CHEBI:456215; EC=6.2.1.15; CC Evidence={ECO:0000269|PubMed:15699031}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19714; CC Evidence={ECO:0000269|PubMed:15699031}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + hexadecanoate = AMP + diphosphate + hexadecanoyl- CC CoA; Xref=Rhea:RHEA:30751, ChEBI:CHEBI:7896, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, CC ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:15469937}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30752; CC Evidence={ECO:0000269|PubMed:15469937}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(9Z)-octadecenoate + ATP + CoA = (9Z)-octadecenoyl-CoA + AMP + CC diphosphate; Xref=Rhea:RHEA:33607, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:30823, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:57387, ChEBI:CHEBI:456215; CC Evidence={ECO:0000250|UniProtKB:Q5K4L6}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33608; CC Evidence={ECO:0000250|UniProtKB:Q5K4L6}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(9Z,12Z)-octadecadienoate + ATP + CoA = (9Z,12Z)- CC octadecadienoyl-CoA + AMP + diphosphate; Xref=Rhea:RHEA:33651, CC ChEBI:CHEBI:30245, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:57383, ChEBI:CHEBI:456215; CC Evidence={ECO:0000250|UniProtKB:Q5K4L6}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33652; CC Evidence={ECO:0000250|UniProtKB:Q5K4L6}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a very long-chain fatty acid + ATP + CoA = a very long-chain CC fatty acyl-CoA + AMP + diphosphate; Xref=Rhea:RHEA:54536, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:58950, ChEBI:CHEBI:138261, ChEBI:CHEBI:456215; CC Evidence={ECO:0000269|PubMed:15469937, ECO:0000269|PubMed:15699031}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54537; CC Evidence={ECO:0000269|PubMed:15469937, ECO:0000269|PubMed:15699031}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + tetracosanoate = AMP + diphosphate + CC tetracosanoyl-CoA; Xref=Rhea:RHEA:33639, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:31014, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:65052, ChEBI:CHEBI:456215; CC Evidence={ECO:0000269|PubMed:15469937, ECO:0000269|PubMed:15699031}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33640; CC Evidence={ECO:0000269|PubMed:15469937, ECO:0000269|PubMed:15699031}; CC -!- SUBCELLULAR LOCATION: Mitochondrion membrane CC {ECO:0000269|PubMed:15469937}; Single-pass membrane protein CC {ECO:0000255}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=O88561-1; Sequence=Displayed; CC Name=2; CC IsoId=O88561-2; Sequence=VSP_016219, VSP_016220; CC -!- TISSUE SPECIFICITY: Expressed at high levels in adrenal gland, testis CC and ovary. Expressed at lower levels in adult brain. Found in adrenal CC cortical cells, spermatocytes and interstitial cells of the testis, CC theca cells of the ovary, cerebral cortical neurons, and cerebellar CC Purkinje cells (at protein level). {ECO:0000269|PubMed:15469937, CC ECO:0000269|PubMed:23936004}. CC -!- DEVELOPMENTAL STAGE: Expressed at higher levels in embryonic brain CC (embryonic days 12-14) than in newborn or adult. CC {ECO:0000269|PubMed:15469937, ECO:0000269|PubMed:23936004}. CC -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH60052.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC Sequence=BAC36120.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BC060052; AAH60052.1; ALT_INIT; mRNA. DR EMBL; AK076014; BAC36120.1; ALT_INIT; mRNA. DR EMBL; AF072758; AAC40187.1; -; mRNA. DR CCDS; CCDS17527.1; -. [O88561-1] DR RefSeq; NP_001303617.1; NM_001316688.1. DR RefSeq; NP_036118.2; NM_011988.3. DR AlphaFoldDB; O88561; -. DR SMR; O88561; -. DR BioGRID; 205024; 2. DR STRING; 10090.ENSMUSP00000029541; -. DR SwissLipids; SLP:000001142; -. DR iPTMnet; O88561; -. DR PhosphoSitePlus; O88561; -. DR MaxQB; O88561; -. DR PaxDb; 10090-ENSMUSP00000029541; -. DR PeptideAtlas; O88561; -. DR ProteomicsDB; 256873; -. [O88561-1] DR ProteomicsDB; 256874; -. [O88561-2] DR DNASU; 26568; -. DR GeneID; 26568; -. DR KEGG; mmu:26568; -. DR AGR; MGI:1347358; -. DR CTD; 11000; -. DR MGI; MGI:1347358; Slc27a3. DR eggNOG; KOG1179; Eukaryota. DR InParanoid; O88561; -. DR OrthoDB; 1650656at2759; -. DR PhylomeDB; O88561; -. DR BRENDA; 6.2.1.3; 3474. DR BioGRID-ORCS; 26568; 1 hit in 78 CRISPR screens. DR PRO; PR:O88561; -. DR Proteomes; UP000000589; Unplaced. DR RNAct; O88561; Protein. DR GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI. DR GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome. DR GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005739; C:mitochondrion; IDA:MGI. DR GO; GO:0047676; F:arachidonate-CoA ligase activity; IEA:UniProtKB-EC. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0004321; F:fatty-acyl-CoA synthase activity; IMP:MGI. DR GO; GO:0005324; F:long-chain fatty acid transporter activity; IBA:GO_Central. DR GO; GO:0004467; F:long-chain fatty acid-CoA ligase activity; ISS:UniProtKB. DR GO; GO:0031957; F:very long-chain fatty acid-CoA ligase activity; ISS:UniProtKB. DR GO; GO:0006637; P:acyl-CoA metabolic process; IC:MGI. DR GO; GO:0001676; P:long-chain fatty acid metabolic process; ISS:UniProtKB. DR CDD; cd05938; hsFATP2a_ACSVL_like; 1. DR Gene3D; 3.30.300.30; -; 1. DR Gene3D; 3.40.50.12780; N-terminal domain of ligase-like; 1. DR InterPro; IPR025110; AMP-bd_C. DR InterPro; IPR045851; AMP-bd_C_sf. DR InterPro; IPR020845; AMP-binding_CS. DR InterPro; IPR000873; AMP-dep_Synth/Lig_com. DR InterPro; IPR042099; ANL_N_sf. DR PANTHER; PTHR43107; LONG-CHAIN FATTY ACID TRANSPORT PROTEIN; 1. DR PANTHER; PTHR43107:SF12; SOLUTE CARRIER FAMILY 27 MEMBER 3; 1. DR Pfam; PF00501; AMP-binding; 1. DR Pfam; PF13193; AMP-binding_C; 1. DR SUPFAM; SSF56801; Acetyl-CoA synthetase-like; 1. DR PROSITE; PS00455; AMP_BINDING; 1. PE 1: Evidence at protein level; KW Alternative splicing; ATP-binding; Fatty acid metabolism; Ligase; KW Lipid metabolism; Lipid transport; Membrane; Mitochondrion; KW Nucleotide-binding; Reference proteome; Transmembrane; Transmembrane helix; KW Transport. FT CHAIN 1..667 FT /note="Long-chain fatty acid transport protein 3" FT /evidence="ECO:0000255" FT /id="PRO_0000193208" FT TRANSMEM 3..23 FT /note="Helical" FT /evidence="ECO:0000255" FT REGION 114..144 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 272..276 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:Q9SMT7" FT BINDING 315 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:Q9SMT7" FT BINDING 412 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:Q9SMT7" FT BINDING 512 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:Q9SMT7" FT BINDING 527 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:Q9SMT7" FT BINDING 619 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:Q9SMT7" FT VAR_SEQ 437..528 FT /note="HIFPFSLIRYDVMTGEPIRNAQGHCMTTSPGEPGLLVAPVSQQSPFLGYAGA FT PELAKDKLLKDVFWSGDVFFNTGDLLVCDEQGFLHFHDRT -> VRDRVDRRTPGAEGG FT MARAGAPGANDAVWLSLPAHLPLLLDSIRCHDRGAYSECPGALHDHISRFVLGGVQSWQ FT TRLNLAPEVGAEPRGSGK (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_016219" FT VAR_SEQ 529..667 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_016220" FT CONFLICT 302 FT /note="Missing (in Ref. 1; AAH60052)" FT /evidence="ECO:0000305" FT CONFLICT 376 FT /note="C -> F (in Ref. 3; AAC40187)" FT /evidence="ECO:0000305" FT CONFLICT 532 FT /note="I -> F (in Ref. 2; BAC36120)" FT /evidence="ECO:0000305" SQ SEQUENCE 667 AA; 72965 MW; 0F343D14952075E7 CRC64; MAALLLLLPL LLLLPLLLKL DVWPQLRWLP ADLAFTVRAL RCKRALRARA LAAAAADPES SESGCSLAWR LAYLAREQPT HTFLIHGAQR FSYAEAERES NRIARAFLRA RGWTGGRRGS GRGSTEEGAR VAPPAGDAAA RGTTAPPLAP GATVALLLPA GPDFLWIWFG LAKAGLRTAF VPTALRRGPL LHCLRSCGAS ALVLATEFLE SLEPDLPALR AMGLHLWATG PETNVAGISN LLSEAADQVD EPVPGYLSAP QNIMDTCLYI FTSGTTGLPK AARISHLKVL QCQGFYHLCG VHQEDVIYLA LPLYHMSGSL LGIVGCLGIG ATVVLKPKFS ASQFWDDCQK HRVTVFQYIG ELCRYLVNQP PSKAECDHKV RLAVGSGLRP DTWERFLRRF GPLQILETYG MTEGNVATFN YTGRQGAVGR ASWLYKHIFP FSLIRYDVMT GEPIRNAQGH CMTTSPGEPG LLVAPVSQQS PFLGYAGAPE LAKDKLLKDV FWSGDVFFNT GDLLVCDEQG FLHFHDRTGD TIRWKGENVA TTEVAEVLET LDFLQEVNIY GVTVPGHEGR AGMAALALRP PQALNLVQLY SHVSENLPPY ARPRFLRLQE SLATTETFKQ QKVRMANEGF DPSVLSDPLY VLDQDIGAYL PLTPARYSAL LSGDLRI //